文献速递主动脉疾病

接受胸主动脉腔内修复术的Stanford B型主动脉夹层患者合并与不合并睡眠呼吸暂停综合征的比较

Comparison of Stanford B Aortic Dissection Patients Who Received Thoracic Endovascular Aortic Repair Combined with or without Sleep Apnea Syndrome.
PubMed 文献 · Ann Vasc Surg · 2018-05-19

该研究回顾性分析了2013年6月至2014年6月在血管外科接受胸主动脉腔内修复术(TEVAR)治疗的134例Stanford B型主动脉夹层患者,根据便携式睡眠监测结果分为睡眠呼吸暂停综合征(SAS)阳性组(n=23)和阴性组(n=111)。SAS阳性组患者更年轻但体重指数更高,住院时间更长,肺部感染、呼吸衰竭、心力衰竭和肾功能衰竭发生率显著更高,但两组中期随访生存率无显著差异。

要点

  • SAS阳性组患者体重指数更高且住院时间更长。
  • SAS阳性组肺部感染、呼吸衰竭、心力衰竭及肾功能衰竭发生率显著更高。
  • 两组中期随访生存率无显著差异(P=0.0846)。

核心结论

  • 合并SAS的Stanford B型主动脉夹层患者体重指数可能更高,TEVAR术后住院时间和ICU停留时间通常更长,并发症发生率更高,但中期随访生存率无显著差异。

研究设计与样本

  • 回顾性研究,纳入2013年6月至2014年6月在血管外科接受TEVAR治疗的Stanford B型主动脉夹层患者134例,根据便携式睡眠监测仪(Nox T3)结果分为SAS阳性组(n=23)和SAS阴性组(n=111)。

主要发现

  • SAS阳性组较SAS阴性组更年轻(54.36±0.97 vs 43.3±1.84,P<0.0001),但体重指数更高(25.48±0.71 vs 22.24±0.23,P<0.0001),住院时间更长(25.52±0.59 vs 15.68±0.27,P<0.0001)。
  • SAS阳性组与SAS阴性组ICU停留时间无显著差异(54.87±12.57 vs 40.27±8.10,P=0.3369)。
  • SAS阳性组肺部感染发生率65.22% vs SAS阴性组13.51%(P<0.0001),呼吸衰竭26.09% vs 1.80%(P=0.003),心力衰竭26.09% vs 3.60%(P=0.0018),肾功能衰竭30.43% vs 5.40%(P=0.0016)。
  • 46个月随访时两组生存率无显著差异(P=0.0846)。
  • SAS阴性组生存时间与所探索的所有因素均无显著相关性;SAS阳性组生存时间仅与肺部感染/衰竭显著相关(r=0.2798,95%CI 0.08741至0.452,P=0.0038)。

临床怎么用

  • 作者认为,对于已诊断为SAS的患者,在TEVAR前后应仔细考虑呼吸系统评估,因为这些患者的生存情况可能与其呼吸状况相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with Stanford B aortic dissection (AD) are usually found to have sleep apnea syndrome (SAS). This condition always complicates the patients' respiration. In this study, we collected and analyzed data of patients' perioperative managements during thoracic endovascular aortic repair (TEVAR) for treating patients with Stanford B AD and SAS. Comparison has been made between the patients with SAS and those without SAS. METHODS: Between June 2013 and June 2014, the clinical data and outcomes of the Stanford B AD patients in the Department of Vascular Surgery in the Second Xiangya Hospital were retrospectively reviewed and studied. According to the result of polysomnography obtained by using a portable polysomnography monitor (Nox T3, Nox Medical Co. Iceland) in TEVAR candidates, patients have been stratified into SAS-positive and SAS-negative group. Comparison of various variables has been made between these 2 groups. RESULTS: One hundred thirty-four patients, with Stanford B AD and treated by TEVAR in our center, were enrolled in this study. Patients' mean age was 52.46 ± 10.84 years. Gender ratio is 114:20, including male 85.07% (114/134) and female 14.93% (20/134). TEVAR was performed in 71.64% (96/134) patients under general anesthesia and 38 patients under local anesthesia. The mean body mass index (BMI) was 23.5 ± 4.2, and the longest follow-up time was 46 months. The patients were stratified into SAS-positive group (n = 23) and SAS-negative group (n = 111). Compared with the patients in the SAS-negative group, those in the SAS-positive group were younger (54.36 ± 0.97 vs. 43.3 ± 1.84 P < 0.0001) but had higher BMI (25.48 ± 0.71 vs. 22.24 ± 0.23, P < 0.0001), with longer hospitalization time (25.52 ± 0.59 vs. 15.68 ± 0.27; P < 0.0001) and without significant differences in the intensive care unit (ICU) stay time (54.87 ± 12.57 vs. 40.27 ± 8.10; P = 0.3369). Furthermore, the complication rate of pulmonary infection (65.22% vs. 13.51%; P < 0.0001), respiratory failure (26.09% vs. 1.80%; P = 0.003), heart failure (26.09% vs. 3.60%; P = 0.0018), and renal failure (30.43% vs. 5.40%; P = 0.0016) are significantly different between SAS-positive and SAS-negative groups. According to the 46-month follow-up, the survival rate of the 2 groups had no significant differences (P = 0.0846). The SAS-negative group result showed that the survival time had no significant correlation with all the factors we explored, whereas the SAS-positive group result showed that the survival time is significantly correlated only with pulmonary infection/failure (r = 0.2798, 95% confidence interval 0.08741 to 0.452, P = 0.0038). CONCLUSIONS: Stanford B AD patients who had SAS are likely to have higher BMI. After treating with TEVAR, they usually have longer hospitalization and ICU stay time, as well as higher complication rate. However, there are no significant differences of the survival rate in midtime follow-up. The respiratory system evaluation should be considered carefully in those patients who have diagnosed as having SAS before and after TEVAR because those patients' survival situation may have correlation with their respiratory condition.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Li X, Cai W, Zhang P, et al. Comparison of Stanford B Aortic Dissection Patients Who Received Thoracic Endovascular Aortic Repair Combined with or without Sleep Apnea Syndrome. Ann Vasc Surg. 2018. PMID: 29783029. doi:10.1016/j.avsg.2018.03.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。